Does AstraZeneca PLC support Israel?

Operates in Israel through AstraZeneca (Israel) Ltd., established at the end of 2008 and based in Kfar Saba, employing over 100 people in sales, marketing and medical & regulatory affairs. The company's own country site describes AstraZeneca Israel as an active part of its global Health Innovation Hubs network alongside the US, China, Sweden and France.

Signed a memorandum of understanding with the Israel Innovation Authority in May 2019 committing to invest in and support the Israeli healthcare ecosystem; the company's BeyondBio Health Innovation Hub in Israel is the fulfilment of that MOU, and its PlayBeyondBio start-up collaboration program runs in partnership with JVP, Yozma Leumit (II2020), Maccabi healthcare, Shaare Zedek medical center, Microsoft and Cisco. AstraZeneca Israel also lists a collaboration with Sheba Medical Center.

Became a founding partner — alongside Merck, Pfizer, Teva, Amazon Web Services and the Israel Biotech Fund — of AION Labs, an AI-driven drug-discovery venture lab launched in October 2021 in the Rehovot Science Park under a tender initiated by the Israel Innovation Authority; start-ups created at the lab receive a minimum of $2 million in funding plus mentorship from the partners.

Set up the "Beam — Illuminating Healthcare Through Data" research center in Tel Aviv with the School of Public Health and School of Medicine at Tel Aviv University and the Leumit and Meuhedet health funds — the second research center of its kind AstraZeneca has established worldwide — to study anonymized Israeli health data for drug research and development.